The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Glycine transporter I inhibitor, N-Methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
(1976) · Medical Entomology and Zoology · Cited by 8,899
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
SIMPSON, G. M., B., M., B., G., ANGUS, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,264
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
A Rating Scale for Drug-Induced Akathisia
Barnes, T. R. E. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.5.672 · Cited by 2,170
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
McDonald, J. W., & Johnston, M. V. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90011-c · Cited by 1,416
D-Alanine Added to Antipsychotics for the Treatment of Schizophrenia
Tsai, G. E., Yang, P., Chang, Y.-C., & Chong, M.-Y. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.032 · Cited by 674
Self-citationGlutamatergic mechanisms in schizophrenia
Tsai, G., & Coyle, J. T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082701.160735 · Cited by 577
Self-citationD-serine added to antipsychotics for the treatment of schizophrenia
Tsai, G., Yang, P., Chung, L.-C., Lange, N., & Coyle, J. T. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00279-0 · Cited by 571
Self-citationEfficacy of High-Dose Glycine in the Treatment of Enduring Negative Symptoms of Schizophrenia
Heresco-Levy, U., Javitt, D. C., Ermilov, M., Mordel, C., Silipo, G., & Lichtenstein, M. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.1.29 · Cited by 487
Goff, D. C., Tsai, G., Levitt, J., Amico, E., Manoach, D., Schoenfeld, D. A., Hayden, D. L., McCarley, R., & Coyle, J. T. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.1.21 · Cited by 436
Self-citationCloning and expression of a glycine transporter reveal colocalization with NMDA receptors
Smith, K. E., Borden, L. A., Hartig, P. R., Branchek, T., & Weinshank, R. L. (1992) · Neuron · doi:10.1016/0896-6273(92)90207-t · Cited by 423
Modulation of N -methyl- d -aspartate receptor function by glycine transport
Bergeron, R., Meyer, T. M., Coyle, J. T., & Greene, R. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15730 · Cited by 411
Kristensen, J. D., Svensson, B., & Gordh, T. (1992) · Pain · doi:10.1016/0304-3959(92)90266-e · Cited by 301
Five-Factor Model of Schizophrenia Initial Validation
LINDENMAYER, J.-P., BERNSTEIN-HYMAN, R., & GROCHOWSKI, S. (1994) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199411000-00006 · Cited by 258
Heresco-Levy, U., Javitt, D. C., Ermilov, M., Mordel, C., Horowitz, A., & Kelly, D. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.169.5.610 · Cited by 255
Glycine enhances NMDA-receptor mediated synaptic potentials in neocortical slices
Thomson, A. M., Walker, V. E., & Flynn, D. M. (1989) · Nature · doi:10.1038/338422a0 · Cited by 233
Chen, L., Muhlhauser, M., & Yang, C. R. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00680.2002 · Cited by 230
Assessing Normality in Random Effects Models
Lange, N., & Ryan, L. (1989) · The Annals of Statistics · doi:10.1214/aos/1176347130 · Cited by 203
Self-citationAdjunctive high-dose glycine in the treatment of schizophrenia
Javitt, D. C., Silipo, G., Cienfuegos, A., Shelley, A.-M., Bark, N., Park, M., Lindenmayer, J.-P., Suckow, R., & Zukin, S. R. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002590 · Cited by 199
Heresco-Levy, U., Ermilov, M., Shimoni, J., Shapira, B., Silipo, G., & Javitt, D. C. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.480 · Cited by 167
McBain, C. J., Kleckner, N. W., Wyrick, S., & Dingledine, R. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09633-6 · Cited by 164
Direct Calcium Binding Results in Activation of Brain Serine Racemase
Cook, S. P., Galve‐Roperh, I., Martínez‐del‐Pozo, Á., & Rodríguez‐Crespo, I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111814200 · Cited by 136
Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients
van Berckel, B. N. M., Hijman, R., van der Linden, J. A., Westenberg, H. G. M., van Ree, J. M., & Kahn, R. S. (1996) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00311-3 · Cited by 109
The Phencyclidine-Glutamate Model of Schizophrenia
Halberstadt, A. L. (1995) · Clinical Neuropharmacology · doi:10.1097/00002826-199506000-00004 · Cited by 104
Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors
Javitt, D. C., Balla, A., Sershen, H. W., & Lajtha, Á. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00237-6 · Cited by 99
Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia
Tsai, G. E., van Kammen, D. P., Chen, S., Kelley, M. E., Grier, A., & Coyle, J. T. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00151-6 · Cited by 80
Self-citationGlycine Agonists: What Can They Teach Us About Schizophrenia?
Farber, N. B., Newcomer, J. W., & Olney, J. W. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.1.13 · Cited by 63
Heresco‐Levy, U., Silipo, G. S., & Javitt, D. (1996) · PubMed · Cited by 53
Molecular cloning and tissue distribution of rat sarcosine dehydrogenase
Bergeron, F., Otto, A., Blache, P., Day, R. W., Denoroy, L., Brandsch, R., & BATAILLE, D. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2570556.x · Cited by 42
d-CPPene (SDZ EAA-494)—A Competitive NMDA Antagonist
Herrling, P. L., Emre, M., & Watkins, J. C. (1997) · Elsevier eBooks · doi:10.1016/b978-012546820-6/50004-9 · Cited by 25
sar: a genetic mouse model for human sarcosinemia generated by ethylnitrosourea mutagenesis.
Harding, C. O., Williams, P. J., Pflanzer, D. M., Colwell, R. E., Lyne, P., & Wolff, J. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2644 · Cited by 21
Cited by
Glutamate receptor ion channels
Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,640
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568
Moghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
“Treatment with the endogenous glycine transport inhibitor sarcosine has also been reported to reduce negative symptoms, improve cognition and further reduce positive symptoms in schizophrenic patients receiving concurrent antipsychotics [47,48].”
BackgroundGlutamate and Schizophrenia: Beyond the Dopamine Hypothesis
Coyle, J. T. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9062-8 · Cited by 917
“fold persistence of the memory of the platform’s location in the Morris water maze (Tsai et al., 2004).”
BackgroundInfluential
Metadata
- Authors
- Tsai, G., Lane, H.-Y., Yang, P., Chong, M.-Y., & Lange, N.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 55
- Issue
- 5
- Pages
- 452-456
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W1981659136
- Cited by
- 342
- References
- 36
- FWCI
- 13.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.